| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 206184-16-9 | Kulomo'opUNALide2 (9CI); L-Isoleucine,N-[(2S,3R)-3-hydroxy-2-methyl-1-oxo-7-octynyl]-L-valyl-N-methyl-L-isoleucyl-(2S)-2-hydroxy-3-methylbutanoyl-L-prolyl-N-methyl-,(5® 1)-lactone; Cyclo[(2S)-2-hydroxy-3-methylbutanoyl-L-prolyl-N-methyl-L-isoleucyl-(2S,3R)-3-hydroxy-2-methyl-7-octynoyl-L-valyl-N-methyl-L-isoleucyl] |  | C38H62N4O8 | 詳情 | 供應(yīng)商 | |
| 220862-05-5 | Phenol,3-[(1E)-2-(3-hydroxyphenyl)ethenyl]-5-methoxy-; ThUNALbene |  | C15H14O3 | 詳情 | 供應(yīng)商 | |
| 63394-05-8 | Propanamide,2-(4-chlorophenoxy)-2-methyl-N-[[(4-morpholinylmethyl)amino]carbonyl]-; ITA 104; Idonor; PerifUNAL; Plafibride |  | C16H22ClN3O4 | 詳情 | 供應(yīng)商 | |
| 72786-10-8 | (E)-4-[[(5Α,6Β)-17-(環(huán)丙基甲基)-4,5-環(huán)氧-3,14-二羥基嗎啡-6-基]氨基]-4-氧-2-丁烯酸甲酯鹽酸鹽 | BETA-FUNALTREXAMINE HYDROCHLORIDE; (E)-[4-[[(5A,6B)-17-CYCLOPROPYLMETHYL]-4,5-EPOXY-3,14-DIHYDROXYMORPHINAN-6-YL]AMINO]-4-OXO-2-BUTENOICACID METHYL ESTER HYDROCHLORIDE; (E)-4-[[(5ALPHA,6BETA)-17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-3,14-DIHYDROXYMORPHINAN-6-YL]AMINO]-4-OXO-2-BUTENOIC ACID METHYL ESTER HYDROCHLORIDE; BETA-FUNALTREXAMINE; BETA-FUNALTREXAMINE HYDROCHLORIDE; BETA-FNA HYDROCHLORIDE; B-FUNALTREXAMINE HYDROCHLORIDE (B-FNA) S PECIFIC NON-EQUILIBR; BETA-FUNALTREXAMINE HCL; (E)-4-((5a,6b)-17-Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl)amino)-4-oxo-2-butenoicacidmethylesterhyd |  | C25H32ClN2O6 | 詳情 | 供應(yīng)商 |